PRMT7 and melanoma: In PRMT7 knockdown or PRMT7 inhibitor-treated murine melanoma B16 cells, MHC-I gene regulators such as Nlrc5 and its target genes are also up-regulated, similar to the MS023 (PRMT1 inhibitor) group (48).